GlobeNewswire 2019-05-10 Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Societ...
GlobeNewswire 2019-05-08 Roche to present new OCREVUS (ocrelizumab) data analyses showing significant reduction of disability...
GlobeNewswire 2019-05-07 Roche presents data from the risdiplam pivotal FIREFISH and SUNFISH studies in spinal muscular atrop...
GlobeNewswire 2019-05-06 FDA approves Roche's Kadcyla for adjuvant treatment of people with HER2-positive early breast cancer...
GlobeNewswire 2019-04-29 New Roche data at the 2019 AAN Annual Meeting showcase breadth and promise of neuroscience portfolio
GlobeNewswire 2019-04-26 Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Re...
GlobeNewswire 2019-04-23 Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer pat...
GlobeNewswire 2019-04-17 Roche reports a strong start in 2019 and raises the outlook for the full-year
TeleTrader 2019-04-03 Roche extends Spark Therapeutics offer to May 2
GlobeNewswire 2019-04-03 Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Re...
GlobeNewswire 2019-04-01 Roche's ipatasertib in combination with Tecentriq and chemotherapy shows promising anti-tumour activ...
GlobeNewswire 2019-03-28 Liquid Biopsy Research Tools, Services and Diagnostics: Global Market Analysis & Outlook Through 201...
GlobeNewswire 2019-03-20 Biopharmaceuticals Market Analysis & Outlook, 2019 to 2024 - Their Ability to Treat Previously Untre...
GlobeNewswire 2019-03-19 FDA approves Roche's Tecentriq in combination with chemotherapy for the initial treatment of adults ...
GlobeNewswire 2019-03-15 European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease
GlobeNewswire 2019-03-14 European Commission approves Roche's Hemlibra for people with severe haemophilia A without factor VI...
GlobeNewswire 2019-03-12 SPARK THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
GlobeNewswire 2019-03-11 Roche's VENTANA PD-L1 (SP142) Assay approved as first companion diagnostic to identify triple-negati...
GlobeNewswire 2019-03-11 FDA grants Roche's Tecentriq in combination with Abraxane accelerated approval for people with PD-L1...
GlobeNewswire 2019-03-08 European Commission approves Roche's Tecentriq in combination with Avastin and chemotherapy for the ...
GlobeNewswire 2019-03-07 Roche commences tender offer for all shares of Spark Therapeutics, Inc. for US$ 114.50 per share in ...
GlobeNewswire 2019-03-07 Roche submits supplemental new drug application to FDA for Venclexta plus Gazyva for previously untr...
GlobeNewswire 2019-03-05 Roche Annual General Meeting 2019
GlobeNewswire 2019-02-28 FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers
GlobeNewswire 2019-02-26 Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Spark Therapeutics, Inc. (ONC...